Skip to main content
HR 2796 104th Congress House

Breast Implant Accountability Act

Official title: To require the surgical removal of silicone gel and saline filled breast implants, to provide for research on silicone and other chemicals used in the manufact… Show full official titleShow less

Official title: To require the surgical removal of silicone gel and saline filled breast implants, to provide for research on silicone and other chemicals used in the manufacture of breast implants, and for other purposes.

Introduced: June 11, 1996 See on congress.gov
Health Artificial implantsBloodChemicalsCivil Rights and Liberties, Minority Issues
More subjectsShow fewer subjects
CommerceDefective productsDiscrimination in medical careDonation of organs, tissues, etc.Economics and Public FinanceEnvironmental ProtectionFederal aid to health facilitiesGovernment Operations and PoliticsGovernment paperworkHospital careInformed consent (Medical law)LawLicensesMammographyMedical ethicsMedical researchPhysiciansProsthesisScience, Technology, CommunicationsSurgeryToxicologyWomenWomen's health
This bill died when the 104th Congress ended
It never became law before the 104th Congress (1995–1996) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 1995
Referred to the Subcommittee on Health and Environment.
Dec 15, 1995
Referred to the House Committee on Commerce.
Dec 15, 1995
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action December 18, 1995

Referred to the Subcommittee on Health and Environment.

 Plain-English summary Congressional Research Service

Breast Implant Accountability Act - Requires each manufacturer of a breast implant to notify each individual with a silicone gel or saline implant implanted before 1994 that the manufacturer will pay for removal and will allow the recipient to select the physician and hospital or center for the removal.

Directs the Secretary of Health and Human Services to conduct or contract for research on the physiological, neurological, and immunological effects of chemicals found in, or used in the manufacture of, breast implants.

Prohibits: (1) physicians from doing silicone breast implants without patient execution of a consent form prescribed by the Secretary and from refusing the treatment of a patient because the patient has received a breast implant; (2) grants to an organ procurement organization if the organization has allowed an individual who has a breast implant to donate an organ; and (3) licensing of any blood collection entity if the entity receives blood from such an individual.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2796: Breast Implant Accountability Act. 104th Congress. Open America. https://openamerica.io/bill/104-HR-2796/
MLA
"H.R. 2796: Breast Implant Accountability Act." 104th Congress, 2026, Open America, https://openamerica.io/bill/104-HR-2796/.
Bluebook (legal)
H.R. 2796, 104th Cong. (2026), https://openamerica.io/bill/104-HR-2796/.
Markdown link
[H.R. 2796: Breast Implant Accountability Act](https://openamerica.io/bill/104-HR-2796/)
Report a problem